Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Influenza

  Free Subscription


09.03.2026

2 Ann Intern Med
1 Antiviral Res
1 Arch Virol
1 J Gen Virol
3 J Immunol
1 J Infect Dis
1 N Engl J Med
1 Pediatrics
1 PLoS Comput Biol
8 PLoS One
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. SACKS HS
    In older adults, high- vs. standard-dose influenza vaccine reduced hospitalization for influenza or pneumonia in those with CKD.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-26-00324.
    PubMed         Abstract available

  2. ANAND R, Glatt AE
    In healthy adults, a modified RNA vs. inactivated influenza vaccine reduced laboratory-confirmed influenza-like illness at >/=14 d.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-05681.
    PubMed         Abstract available


    Antiviral Res

  3. RUDRAMURTHY GR, Gudla CS, Harisha R, Selvam V, et al
    FNDR-11124, a broad-spectrum small molecule inhibitor of viral RNA polymerase, restricts replication of SARS-CoV-2 and Influenza virus in vitro and in vivo.
    Antiviral Res. 2026 Mar 2:106382. doi: 10.1016/j.antiviral.2026.106382.
    PubMed         Abstract available


    Arch Virol

  4. DUTTA M, Sarmah N, Siddique AI, Borah P, et al
    Temporal trends and burden of influenza B virus lineages in Dibrugarh, Assam (2014-2025): predominance of Victoria with early circulation of Yamagata.
    Arch Virol. 2026;171:110.
    PubMed        


    J Gen Virol

  5. GROSS J, Pouget B, Sarrat M, Foret-Lucas C, et al
    In vivo inhibition of JAK-STAT signalling enhances high pathogenicity influenza virus replication in ducks.
    J Gen Virol. 2026;107:002238.
    PubMed         Abstract available


    J Immunol

  6. WERNINGHAUS IC, Hinke DM, Katta K, Bogen B, et al
    A combinatorial DNA vaccine encoding APC-targeted, bivalent HA and NA antigens results in an improved influenza vaccine.
    J Immunol. 2026;215:vkaf378.
    PubMed         Abstract available

  7. SHARMA SB, Kumar K, Parchment N, Eggleston T, et al
    Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression.
    J Immunol. 2026;215:vkaf365.
    PubMed         Abstract available

  8. SOUDANI N, Sidney J, Da Silva Antunes R, Case JB, et al
    Identification of immunodominant T cell epitopes in SARS-CoV-2 spike protein in Syrian hamsters.
    J Immunol. 2026;215:vkaf342.
    PubMed         Abstract available


    J Infect Dis

  9. WANG L, Wang J, Hossain J, Cooper HC, et al
    Development and Characterization of Candidate Vaccine Viruses against High Pathogenicity Avian Influenza A(H5) Viruses for Rapid Pandemic Response.
    J Infect Dis. 2026 Feb 28:jiag132. doi: 10.1093.
    PubMed         Abstract available


    N Engl J Med

  10. GABET A, Bernard C, Zureik M
    Updated Evidence Base for Covid-19, RSV, and Influenza Immunizations.
    N Engl J Med. 2026;394:10.
    PubMed        


    Pediatrics

  11. TSUNG S, Zeng YB, Shah K, Asch SM, et al
    Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants.
    Pediatrics. 2026 Feb 20:e2025071558. doi: 10.1542/peds.2025-071558.
    PubMed         Abstract available


    PLoS Comput Biol

  12. CRAIG M, Deng X, McLeod DV
    Viral evolution during primary infection in immunocompromised hosts.
    PLoS Comput Biol. 2026;22:e1013967.
    PubMed         Abstract available


    PLoS One

  13. RAHIMNAHAL S, Yousefizadeh S, Mohammadi Y
    Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.
    PLoS One. 2026;21:e0334662.
    PubMed         Abstract available

  14. RATREE S, Assavapokee N, Santibenchakul S, Sirisabya N, et al
    Reported adverse events following COVID-19 vaccination in gynecologic cancer patients in Thailand: A descriptive study.
    PLoS One. 2026;21:e0342303.
    PubMed         Abstract available

  15. DEMPSEY LF, Osuka H, McGovern OL, Munita JM, et al
    Antimicrobial use and documented infection among hospitalized adults in South American acute care facilities during the coronavirus disease 2019 (COVID-19) pandemic.
    PLoS One. 2026;21:e0343535.
    PubMed         Abstract available

  16. SHKOLNIKOV VM, Timonin S, Jdanov D, Medina-Jaudes N, et al
    Widening East-West inequality in life expectancy in Europe during the COVID-19 pandemic: An international comparative study.
    PLoS One. 2026;21:e0344003.
    PubMed         Abstract available

  17. MEYER F, Traidl S, Ameri M, Dreher A, et al
    Distinguishing post-COVID from long-COVID in adults: Development and validation of a biomarker signature using targeted proteomics and machine learning in a cross-sectional observational study.
    PLoS One. 2026;21:e0338451.
    PubMed         Abstract available

  18. FIAZ N, Basheer A, Zahoor I, Naveed S, et al
    Distinct mutational landscapes and phylogenomic insights of the SARS-CoV-2 delta variant in Pakistan and India: Regional evolution, novel mutations, and epidemiological implications.
    PLoS One. 2026;21:e0340704.
    PubMed         Abstract available

  19. GUTIERREZ-SIGUT E, Lamarche V, Rowley K, Lago EF, et al
    Access to information in deaf and hard-of-hearing people.
    PLoS One. 2026;21:e0343904.
    PubMed         Abstract available

  20. PAVON R, Parra S, Rubio FJ, Feliu M, et al
    Assessment of physical status and analysis of lipidomic and metabolomic alterations in patients with Post-COVID-19 condition.
    PLoS One. 2026;21:e0341192.
    PubMed         Abstract available


    Virology

  21. BARMAN S, Iyengar R, Miller L, Turner JCM, et al
    Reverse genetic rescue and propagation of human influenza A(H3N2) master virus seed in HEK-293 suspension cells.
    Virology. 2026;618:110862.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum